{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:34:17Z","timestamp":1788377657792,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hypertrophic scars (HTSs) are the result of an abnormal healing process resulting from burns and other severe traumas. The symptoms of that condition include skin irritation, discomfort, and itching. This study aimed to assess the efficacy of fractional carbon dioxide (CO\n                    <jats:sub>2<\/jats:sub>\n                    ) laser therapy alone or with triamcinolone or 5-fluorouracil (FU) in the treatment of early post-burn hypertrophic scars (HTSs) that develop during the first 6 months after the injury. A prospective, randomized, single-blind comparative study was conducted on 30 patients aged 16\u201365 with hypertrophic scars (HTS) resulting from burns. Patients had no prior treatment for their scars. We randomly assigned participants to one of three groups: Group A received fractional CO\n                    <jats:sub>2<\/jats:sub>\n                    laser therapy alone, Group B received fractional CO\n                    <jats:sub>2<\/jats:sub>\n                    laser therapy with topical 5-fluorouracil, and Group C received fractional CO\n                    <jats:sub>2<\/jats:sub>\n                    laser therapy with topical triamcinolone acetonide. All treatment groups showed significant improvements (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) in overall scar severity and height. Patients in Group C (fractional CO\n                    <jats:sub>2<\/jats:sub>\n                    laser\u2009+\u2009triamcinolone) demonstrated significant improvements in scar pliability, height, and pigmentation (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). In contrast, patients in Group B (fractional CO\n                    <jats:sub>2<\/jats:sub>\n                    laser\u2009+\u20095-FU) showed significant reductions in scar vascularity, pliability, and height following treatment (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). While all groups reported minor changes in pain and itching, there were no significant differences in these symptoms between Group B and Group C. HTSs of this trial revealed reductions in overall scar surface area and thickness and improvement of pliability and pigmentation; however, there was not statistically significant difference between the effect of 5-fluorouracil and triamcinolone acetonide (TAC), suggesting that neither drug offers better efficacy over the other. Level I, singleblinded randomized control study.\n                  <\/jats:p>","DOI":"10.1007\/s10103-024-04256-z","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T23:32:25Z","timestamp":1737588745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy of fractional CO2 laser with or without triamcinolone acetonide or 5-fluorouracil in the treatment of early postburn hypertrophic scars"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2810-1177","authenticated-orcid":false,"given":"Bassel","family":"Younes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed","family":"Mandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Soliman Hashish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Gamal Shoukr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"4256_CR1","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.3390\/ijms25094674","volume":"25","author":"T Murakami","year":"2024","unstructured":"Murakami T, Shigeki S (2024) Pharmacotherapy for keloids and hypertrophic scars. Int J Mol Sci 25:4674\u20134679","journal-title":"Int J Mol Sci"},{"key":"4256_CR2","unstructured":"Krakowski AC, Shumaker PR (2017) The scar book: formation, mitigation, rehabilitation and prevention. Lippincott Williams & Wilkins"},{"key":"4256_CR3","doi-asserted-by":"crossref","unstructured":"Miletta N, Siwy K, Hivnor C, Clark J, Shofner J, Zurakowski D et al (2021) Fractional ablative laser therapy is an effective treatment for hypertrophic burn scars: A prospective study of objective and subjective outcomes. Ann Surg 274:e574-e58010.1097\/sla.0000000000003576","DOI":"10.1097\/SLA.0000000000003576"},{"key":"4256_CR4","doi-asserted-by":"crossref","unstructured":"Willows BM, Ilyas M, Sharma A (2017) Laser in the management of burn scars. Burns 43:1379-138910.1016\/j.burns.2017.07.001","DOI":"10.1016\/j.burns.2017.07.001"},{"key":"4256_CR5","doi-asserted-by":"crossref","unstructured":"Safra T, Shehadeh W, Koren A, Salameh F, Friedman O, Sprecher E et al (2019) Early intervention with pulse dye and CO(2) ablative fractional lasers to improve cutaneous scarring post-lumpectomy: a randomized controlled trial on the impact of intervention on final cosmesis. Lasers Med Sci 34:1881-188710.1007\/s10103-019-02788-3","DOI":"10.1007\/s10103-019-02788-3"},{"key":"4256_CR6","doi-asserted-by":"crossref","unstructured":"Haurani MJ, Foreman K, Yang JJ, Siddiqui A (2009) 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 123:139-14810.1097\/PRS.0b013e3181904d1b","DOI":"10.1097\/PRS.0b013e3181904d1b"},{"key":"4256_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00006534-200208000-00031","volume":"110","author":"TA Mustoe","year":"2002","unstructured":"Mustoe TA, Cooter RD, Gold MH, Hobbs FR, Ramelet A-A, Shakespeare PG et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110:560\u2013571","journal-title":"Plast Reconstr Surg"},{"key":"4256_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1534734608320786","volume":"7","author":"C Roques","year":"2008","unstructured":"Roques C, T\u00e9ot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7:137\u2013145","journal-title":"Int J Low Extrem Wounds"},{"key":"4256_CR9","doi-asserted-by":"crossref","unstructured":"Leventhal D, Furr M, Reiter D (2006) Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 8:362-36810.1001\/archfaci.8.6.362","DOI":"10.1001\/archfaci.8.6.362"},{"key":"4256_CR10","doi-asserted-by":"crossref","unstructured":"Carroll LA, Hanasono MM, Mikulec AA, Kita M, Koch RJ (2002) Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg 28:704-70910.1046\/j.1524-4725.2002.02012.x","DOI":"10.1046\/j.1524-4725.2002.02012.x"},{"key":"4256_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/lsm.22055","volume":"44","author":"AL Le Qu","year":"2012","unstructured":"Le Qu AL, Zhou L, He C, Grossman PH, Moy RL, Mi Q-S et al (2012) Clinical and molecular effects on mature burn scars after treatment with a fractional CO2 laser. Lasers Surg Med 44:517\u2013524","journal-title":"Lasers Surg Med"},{"key":"4256_CR12","doi-asserted-by":"crossref","unstructured":"Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW et al (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113:1960-196610.1097\/01.prs.0000122207.28773.56","DOI":"10.1097\/01.PRS.0000122207.28773.56"},{"key":"4256_CR13","first-page":"239","volume":"7","author":"Z Zhu","year":"2013","unstructured":"Zhu Z, Ding J, Shankowsky HA, Tredget EE (2013) The molecular mechanism of hypertrophic scar. CCS 7:239\u2013252","journal-title":"CCS"},{"key":"4256_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0738-081X(94)90254-2","volume":"12","author":"JC Murray","year":"1994","unstructured":"Murray JC (1994) Keloids and hypertrophic scars. Clin Dermatol 12:27\u201337","journal-title":"Clin Dermatol"},{"key":"4256_CR15","doi-asserted-by":"crossref","unstructured":"Waibel JS, Wulkan AJ, Rudnick A, Daoud A (2019) Treatment of hypertrophic scars using laser-assisted corticosteroid versus laser-assisted 5-fluorouracil delivery. Dermatol Surg 45:423-43010.1097\/dss.0000000000001678","DOI":"10.1097\/DSS.0000000000001678"},{"key":"4256_CR16","doi-asserted-by":"crossref","unstructured":"Waibel JS, Wulkan AJ, Shumaker PR (2013) Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med 45:135-14010.1002\/lsm.22120","DOI":"10.1002\/lsm.22120"},{"key":"4256_CR17","doi-asserted-by":"crossref","unstructured":"El-Zawahry BM, Sobhi RM, Bassiouny DA, Tabak SA (2015) Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open-label controlled clinical and histopathological study. J Cosmet Dermatol 14:324-33110.1111\/jocd.12163","DOI":"10.1111\/jocd.12163"},{"key":"4256_CR18","doi-asserted-by":"crossref","unstructured":"Azzam OA, Bassiouny DA, El-Hawary MS, El Maadawi ZM, Sobhi RM, El-Mesidy MS (2016) Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study. Lasers Med Sci 31:9-1810.1007\/s10103-015-1824-4","DOI":"10.1007\/s10103-015-1824-4"},{"key":"4256_CR19","doi-asserted-by":"crossref","unstructured":"Haak CS, Farinelli WA, Tam J, Doukas AG, Anderson RR, Haedersdal M (2012) Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time. Lasers Surg Med 44:787-79510.1002\/lsm.22102","DOI":"10.1002\/lsm.22102"},{"key":"4256_CR20","doi-asserted-by":"crossref","unstructured":"Cavali\u00e9 M, Sillard L, Montaudi\u00e9 H, Bahadoran P, Lacour JP, Passeron T (2015) Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther 28:74-7810.1111\/dth.12187","DOI":"10.1111\/dth.12187"},{"key":"4256_CR21","doi-asserted-by":"crossref","unstructured":"Issa MC, Kassuga LE, Chevrand NS, Pires MT (2013) Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment. Int J Dermatol 52:367-37010.1111\/j.1365-4632.2012.05704.x","DOI":"10.1111\/j.1365-4632.2012.05704.x"},{"key":"4256_CR22","doi-asserted-by":"crossref","unstructured":"Zhuang Z, Li Y, Wei X (2021) The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. Burns 47:987-99810.1016\/j.burns.2021.02.013","DOI":"10.1016\/j.burns.2021.02.013"},{"key":"4256_CR23","doi-asserted-by":"crossref","unstructured":"Prince GT, Cameron MC, Fathi R, Alkousakis T (2018) Topical 5-fluorouracil in dermatologic disease. Int J Dermatol 57:1259-126410.1111\/ijd.14106","DOI":"10.1111\/ijd.14106"},{"key":"4256_CR24","doi-asserted-by":"crossref","unstructured":"Nanda S, Reddy BS (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 30:54\u201356; discussion 56-5710.1111\/j.1524-4725.2004.29382.x","DOI":"10.1111\/j.1524-4725.2004.29382.x"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-024-04256-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:23:58Z","timestamp":1771399438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-024-04256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1007\/s10103-024-04256-z","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from the Ethical Committee of Tanta University Hospitals in Tanta, Egypt (approval code: 36156\/12\/22).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was obtained from all participants, or from a parent or guardian in cases where participants were unable to provide consent, covering participation, photography, and publication of research findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}